Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy

Journal of Surgical Oncology

Volumn 98, Issue 5, 2008, Pages 309-313

  Uemura, Kenichiro ^a   Murakami, Yoshiaki ^a   Hayashidani, Yasuo ^a   Sudo, Takeshi ^a   Hashimoto, Yasushi ^a   Ohge, Hiroki ^a   Sueda, Taijiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Pancreatic fistula; Pancreaticoduodenectomy; Postoperative pancreatitis; Ulinastatin

Indexed keywords

AMYLASE; PLACEBO; TRYPSINOGEN; TRYPSINOGEN 2; ULINASTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRAIN; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; HYPERAMYLASEMIA; MALE; PANCREAS CANCER; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PANCREATICOJEJUNOSTOMY; PANCREATITIS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; DOUBLE-BLIND METHOD; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PANCREATITIS; TREATMENT OUTCOME; TRYPSIN; TRYPSIN INHIBITORS; TRYPSINOGEN;

EID: 53549093061     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21098     Document Type: Article

References (30)

1. Ohnishi H, Kosuzume H, Ashida Y, et al.: Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig Dis Sci 1984;29:26-32.
2. Tsujino T, Komatsu Y, Isayama H, et al.: Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial. Clin Gastroenterol Hepatol 2005;3:376-383.
3. Raty S, Sand J, Nordback I: Detection of postoperative pancreatitis after pancreatic surgery by urine trypsinogen strip test. Br J Surg 2006;94:64-69.
4. Bassi C, Dervenis C, Butturini G, et al.: Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery 2005;138:8-13.
5. Bassi C, Falconi M, Molinari E, et al.: Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: Results of a comparative study. Ann Surg 2005;242:767-771; discussion 771-763.
6. Park YC, Kim SW, Jang JY, et al.: Factors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy. J Am Coll Surg 2003;196:859-865.
7. Winter JM, Cameron JL, Campbell KA, et al.: 1423 Pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006;10:1199-1211.
8. Duffas JP, Sue B, Msika S, et al.: A controlled randomized multicenter trial of pancreatogastrostomy or pancreatojejunostomy after pancreatoduodenectomy. Am J Surg 2005;189:720-729.
9. Raty S, Sand J, Lantto E, et al.: Postoperative acute pancreatitis as a major determinant of postoperative delayed gastric emptying after pancreaticoduodenectomy. J Gastrointest Surg 2006;10:1131-1139.
10. Itkonen O, Koivunen E, Hurme M, et al.: Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;115:712-718.
11. Hedstrom J, Sainio V, Kemppainen E, et al.: Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: Clinical study in consecutive patients. Br Med J 1996;313:333-337.
12. Hedstrom J, Korvuo A, Kenkimaki P, et al.: Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet 1996;347:729-730.
13. Kemppainen EA, Hedstrom JI, Puolakkainen PA, et al.: Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med 1997;336:1788-1793.
14. Neoptolemos JP, Kemppainen EA, Mayer JM, et al.: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study. Lancet 2000;355:1955-1960.
15. Kylanpaa-Back ML, Kemppainen E, Puolakkainen P, et al.: Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis. Hepatogastroenterology 2002;49:1130-1134.
16. Fujishiro H, Adachi K, Imaoka T, et al.: Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroenterol Hepatol 2006;21:1065-1069.
17. Ueki T, Otani K, Kawamoto K, et al.: Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A prospective, randomized trial. J Gastroenterol 2007;42:161-167.
18. McKay A, Mackenzie S, Sutherland FR, et al.: Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 2006;93:929-936.
19. Wente MN, Shrikhande SV, Muller MW, et al.: Pancreaticojejunostomy versus pancreaticogastrostomy: Systematic review and meta-analysis. Am J Surg 2007;193:171-183.
20. Payne RF, Pain JA: Duct-to-mucosa pancreaticogastrostomy is a safe anastomosis following pancreaticoduodenectomy. Br J Surg 2006;93:73-77.
21. Lin JW, Cameron JL, Yeo CJ, et al.: Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 2004;8:951-959.
22. Muscari F, Sue B, Kirzin S, et al.: Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: Multivariate analysis in 300 patients. Surgery 2006;139:591-598.
23. Yang YM, Tian XD, Zhuang Y, et al.: Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 2005;11:2456-2461.
24. Aranha GV, Aaron JM, Shoup M, et al.: Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery 2006;140:561-568; discussion 568-569.
25. Buchler M, Friess H, Klempa I, et al.: Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992;163:125-130; discussion 130-121.
26. Pederzoli P, Bassi C, Falconi M, et al.: Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 1994;81:265-269.
27. Friess H, Beger HG, Sulkowski U, et al.: Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82:1270-1273.
28. Montorsi M, Zago M, Mosca F, et al.: Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized clinical trial. Surgery 1995;117:26-31.
29. Lowy AM, Lee JE, Pisters PW, et al.: Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 1997;226:632-641.
30. Yeo CJ, Cameron JL, Lillemoe KD, et al.: Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 2000;232:419-429.